Literature DB >> 16790790

Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H.

T Meri1, S J Cutler, A M Blom, S Meri, T S Jokiranta.   

Abstract

Relapsing fever is a rapidly progressive and severe septic disease caused by certain Borrelia spirochetes. The disease is divided into two forms, i.e., epidemic relapsing fever, caused by Borrelia recurrentis and transmitted by lice, and the endemic form, caused by several Borrelia species, such as B. duttonii, and transmitted by soft-bodied ticks. The spirochetes enter the bloodstream by the vector bite and live persistently in plasma even after the development of specific antibodies. This leads to fever relapses and high mortality and clearly indicates that the Borrelia organisms utilize effective immune evasion strategies. In this study, we show that the epidemic relapsing fever pathogen B. recurrentis and an endemic relapsing fever pathogen, B. duttonii, are serum resistant, i.e., resistant to complement in vitro. They acquire the host alternative complement pathway regulator factor H on their surfaces in a similar way to that of the less serum-resistant Lyme disease pathogen, B. burgdorferi sensu stricto. More importantly, the relapsing fever spirochetes specifically bind host C4b-binding protein, a major regulator of the antibody-mediated classical complement pathway. Both complement regulators retained their functional activities when bound to the surfaces of the spirochetes. In conclusion, this is the first report of complement evasion by Borrelia recurrentis and B. duttonii and the first report showing capture of C4b-binding protein by spirochetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790790      PMCID: PMC1489703          DOI: 10.1128/IAI.00007-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi.

Authors:  S Breitner-Ruddock; R Würzner; J Schulze; V Brade
Journal:  Med Microbiol Immunol       Date:  1997-03       Impact factor: 3.402

2.  Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis.

Authors:  Antti Alitalo; Taru Meri; Pär Comstedt; Luke Jeffery; Johanna Tornberg; Tomas Strandin; Hilkka Lankinen; Sven Bergström; Marina Cinco; Santosh R Vuppala; Darrin R Akins; Seppo Meri
Journal:  Eur J Immunol       Date:  2005-10       Impact factor: 5.532

3.  Successful in-vitro cultivation of Borrelia recurrentis.

Authors:  S J Cutler; D Fekade; K Hussein; K A Knox; A Melka; K Cann; A R Emilianus; D A Warrell; D J Wright
Journal:  Lancet       Date:  1994-01-22       Impact factor: 79.321

4.  Epidemic of louse-borne relapsing fever in Ethiopia.

Authors:  K O Sundnes; A T Haimanot
Journal:  Lancet       Date:  1993-11-13       Impact factor: 79.321

5.  Activation of a vmp pseudogene in Borrelia hermsii: an alternate mechanism of antigenic variation during relapsing fever.

Authors:  B I Restrepo; C J Carter; A G Barbour
Journal:  Mol Microbiol       Date:  1994-07       Impact factor: 3.501

6.  Successful in vitro cultivation of Borrelia duttonii and its comparison with Borrelia recurrentis.

Authors:  S J Cutler; C O Akintunde; J Moss; M Fukunaga; K Kurtenbach; A Talbert; H Zhang; D J Wright; D A Warrell
Journal:  Int J Syst Bacteriol       Date:  1999-10

7.  Antigenic variation of Borrelia turicatae Vsp surface lipoproteins occurs in vitro and generates novel serotypes.

Authors:  N M Ras; D Postic; P Ave; M Huerre; G Baranton
Journal:  Res Microbiol       Date:  2000 Jan-Feb       Impact factor: 3.992

8.  Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement.

Authors:  R Misasi; H P Huemer; W Schwaeble; E Sölder; C Larcher; M P Dierich
Journal:  Eur J Immunol       Date:  1989-09       Impact factor: 5.532

Review 9.  Antigenic variation in vector-borne pathogens.

Authors:  A G Barbour; B I Restrepo
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

10.  Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae.

Authors:  S Ram; D P McQuillen; S Gulati; C Elkins; M K Pangburn; P A Rice
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more
  34 in total

1.  Immune evasion of leptospira species by acquisition of human complement regulator C4BP.

Authors:  Angela S Barbosa; Patricia A E Abreu; Sílvio A Vasconcellos; Zenaide M Morais; Amane P Gonçales; Aldacilene S Silva; Mohamed R Daha; Lourdes Isaac
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

2.  The Borrelia hermsii factor H binding protein FhbA is not required for infectivity in mice or for resistance to human complement in vitro.

Authors:  Lindy M Fine; Daniel P Miller; Katherine L Mallory; Brittney K Tegels; Christopher G Earnhart; Richard T Marconi
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

3.  Molecular characterization of the interaction of Borrelia parkeri and Borrelia turicatae with human complement regulators.

Authors:  Melanie Schott; Sonja Grosskinsky; Christiane Brenner; Peter Kraiczy; Reinhard Wallich
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

4.  Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).

Authors:  Nenoo Rawal; Rema Rajagopalan; Veena P Salvi
Journal:  Mol Immunol       Date:  2009-08-05       Impact factor: 4.407

5.  Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Markus M Simon; Reinhard Wallich
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

6.  Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein.

Authors:  G Vogl; I Lesiak; D B Jensen; S Perkhofer; R Eck; C Speth; C Lass-Flörl; P F Zipfel; A M Blom; M P Dierich; R Würzner
Journal:  Mol Immunol       Date:  2007-10-25       Impact factor: 4.407

7.  Analysis of a unique interaction between the complement regulatory protein factor H and the periodontal pathogen Treponema denticola.

Authors:  John V McDowell; Bernice Huang; J Christopher Fenno; Richard T Marconi
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

8.  Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells.

Authors:  David Ermert; Antonin Weckel; Vaibhav Agarwal; Inga-Maria Frick; Lars Björck; Anna M Blom
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

9.  Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Peter Kraiczy; Peter F Zipfel; Markus M Simon; Reinhard Wallich
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

10.  A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice.

Authors:  Christer Larsson; Jenny Lundqvist; Nico van Rooijen; Sven Bergström
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.